The most worrisome aspect is that most water woes are the result of mismanagement
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.
The poor performance of capital goods - a bellwether for future growth - has alarmed most analysts
It accounted for over a third of foreign direct investment flows into India between 2000 and 2015
The draft bill allows euthanasia for patients who can take informed decisions; doctors to be protected from liability.
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
New data show tax reform, better tracking needed
NHAI to pull plug on Rs 3,000-crore ventures for poor show
Sanjeev Vashishta, chief executive officer at SRL Diagnostics, talks to Deepak Patel about expansion plans and regulations for the sector.
In most cases, they dodged bullets and, in some, recovered the same day
Govt bans brands with annual sales worth Rs 3,728 crore.
Between 2011 and 2014, they indirectly determined the price of tyres in the market, says report
Lobby group tells USTR it has got assurance from India on compulsory licensing.
A dialysis machine contributes only 6 per cent to the overall cost.
'As of now there are no mining activities,' but 'who knows the future?'
If the real economy is indeed looking up, then it no longer needs hand-holding and fiscal laxity
Modi must focus on other state-level reforms, such as those in labour laws, leasing of land and agriculture
Many fear that in practice if banks make their customers pay to hold their money, it might lead to a situation where consumers hold on to cash.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances